Cell Providers Face New Challenges From Surprising Source
Telecom giants are losing market share to cable companies as bundling strategies drive lower churn and stronger customer retention in the wireless sector.
CoreWeave’s $7B Lifeline Buys Time for Applied Digital Amid Growing AI Infrastructure Doubts
Applied Digital inks a 7 billion dollar lease with CoreWeave, highlighting the high-stakes debt financing fueling current AI infrastructure expansion.
Discount Retailers Are Winning Back Shoppers In the Era of Inflation After Years of Losing Them to Legacy Chains
Budget retailers like Dollar General gain as inflation pushes shoppers away from traditional stores, though tariff costs weigh on some discount chains.
Sanofi Struggled To Impress Shareholders For Years — Will Over A Dozen New Products and $10B In Acquisitions Change That?
Sanofi is shedding non-core assets and spending billions on acquisitions to secure its future beyond blockbuster drug Dupixent.
Boeing Scores Big As US Judge Throws Out Trial, Clearing Way For Airline To Put MAX Disaster Behind It
Boeing shares gain momentum as a federal judge cancels a trial over 737 MAX crashes, allowing the aerospace company to focus on production and growth.
Language App Duolingo Learns That AI Doesn’t Mean ‘Good’ To Everybody: A Cautionary Tale For “AI First” Brands
Duolingo's recent pivot to an AI-first strategy highlights the risks companies face when consumer sentiment clashes with corporate efficiency goals.
Costco Delivers Strong Quarter While Navigating Tariff Turbulence
Costco reports strong quarterly results, utilizing its massive buying power to navigate retail tariff challenges while competitors raise prices.
America’s Wealthy Are All In on American Exceptionalism, Says UBS Survey
A new UBS survey reveals that the ultra-wealthy are doubling down on US stocks, signaling strong confidence despite macro headwinds and global uncertainty.
No Geek Squad Fix For Tariff Headaches As Best Buy Tumbles 7.3%
Best Buy shares fell over 7% after the retailer missed revenue targets and lowered its full-year outlook amid ongoing tariff-related supply chain challenges.
Retail’s Tariff Tug-Of-War Splits Earnings As Abercrombie Surges While Macy’s Slashes Guidance
Retailers navigate rising tariff costs through price hikes and supply chain shifts, leading to divergent earnings outcomes for major brands.
In 2024, 4% of Americans Took GLP-1s Like Ozempic and Mounjaro
Four percent of US adults used GLP-1 medications like Ozempic in 2024, driving shifts in restaurant patronage and packaged food demand.
